Table 1.

Gene panel–based on human cancer inflammation and immunity from PCR–array data

Gene	Fold change	log2FC	Gene	Fold change	log2FC	Gene	Fold change	log2FC
ACKR3	5.76	2.53	CXCL9	0.24	–2.06	IL6	1.83	0.87
BCL2	0.65	–0.62	CXCR1	2.76	1.46	CXCL8	0.97	–0.04
BCL2L1	0.73	–0.45	CXCR2	2.57	1.36	IRF1	1.02	0.03
CXCL11	0.73	–0.45	CXCR3	2.05	1.04	KITLG	0.80	–0.32
CCL2	0.95	–0.07	CXCR4	3.21	1.68	MICA	2.10	1.07
CCL20	1.53	0.61	CXCR5	1.08	0.11	MICB	1.36	0.44
CCL21	1.84	0.88	EGF	1.18	0.24	MIF	1.69	0.76
CCL22	0.38	–1.40	EGFR	1.03	0.04	MYD88	1.05	0.07
CCL28	1.06	0.08	FASLG	1.40	0.49	NFkB1	0.79	–0.34
CCL4	1.13	0.18	FOXP3	1.62	0.70	NOS2	2.32	1.21
CSF2	1.13	0.18	GBP1	0.81	–0.30	PDCD1	4.87	2.28
CCL5	3.27	1.71	GZMA	7.21	2.85	SPP1	2.78	1.48
CCR1	9.21	3.20	GZMB	4.32	2.11	STAT1	0.72	–0.47
CCR10	0.88	–0.18	HIF1A	0.96	–0.06	STAT3	0.76	–0.40
TLR2	0.88	–0.18	HLA–A	1.46	0.55	TGFB1	0.86	–0.22
CCR2	1.52	0.60	HLA–B	2.55	1.35	TLR3	1.26	0.33
CCR4	5.78	2.53	HLA–C	1.15	0.20	TLR4	1.26	0.33
CCR7	3.49	1.80	IDO1	0.53	–0.92	TNF	1.38	0.46
CCR9	0.94	–0.09	IFNG	3.23	1.69	TNFSF10	0.67	–0.58
CD274	0.74	–0.43	IGF1	3.50	1.81	TP53	1.74	0.80
CSF1	1.22	0.29	IL10	2.95	1.56	VEGFA	3.26	1.70
CSF3	0.50	–1.00	IL12A	0.54	–0.89
CTLA4	1.25	0.32	IL12B	12.98	3.70
CXCL1	0.21	–2.25	IL13	4.54	2.18
CXCL10	0.59	–0.76	IL15	1.77	0.82
CXCL12	1.59	0.67	IL17A	4.67	2.22
MYC	1.59	0.67	IL1A	2.42	1.28
CXCL2	0.31	–1.69	IL1B	0.57	–0.81
CXCL5	0.56	–0.84	IL23A	1.73	0.79
PTGS2	0.56	–0.84	IL4	11.30	3.50